• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect
virtually any organ. Although the lung is typically the most common organ involved …

Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous …

Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Background There is limited consensus regarding the relative diagnostic performance of
cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac sarcoidosis. Purpose To perform …

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in
cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …

Background There is no consensus regarding the relative prognostic value of cardiac MRI
and fluorodeoxyglucose (FDG) PET in cardiac sarcoidosis. Purpose To perform a systematic …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Objectives The purpose of this study was to investigate the diagnostic value of simultaneous
hybrid cardiac magnetic resonance (CMR) and 18F-fluorodeoxyglucose positron emission …

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …